GSK2256098
GSK2256098 Uses, Dosage, Side Effects, Food Interaction and all others data.
GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas).
| Trade Name | GSK2256098 |
| Generic | GSK2256098 |
| Type | |
| Formula | C20H23ClN6O2 |
| Weight | Average: 414.89 Monoisotopic: 414.1571017 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here GSK2256098
